IndraLab
Statements
sparser
"One possible problematic outcome of such dismissal is that patients, who already anticipate this negative response, may choose not to discuss their concurrent use of treatments with their HCP, and as such may assume the entire burden of managing the interactions of CM and CAM without any medical guidance, which puts them at a great health risk [ xref , xref ]."